Her Chairman Paul Hopper has extensive experience. He will guide her. IMU is virtual Biotech company with 7 staff. Everything else is contracted out including managing ASX obligations.
So in essence LC only manages relationships, partnerships., research teams and of course trials which are her main game.
I’m not in any way concerned about novice management. Most ASX listed Biotechs do have BoD’s and CEO’s with L plates on.
IMU has world class experience.
Media Thread, page-3129
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.001(2.44%) |
Mkt cap ! $312.4M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.3¢ | 4.1¢ | $672.3K | 16.04M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 4003556 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 197261 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |